Michael D. Latham
About
In The Last Decade
Michael D. Latham
10 papers receiving 384 citations
Peers
Comparison fields: 5 of 53
- Molecular Biology 328
- Oncology 167
- Organic Chemistry 69
- Toxicology 56
- Plant Science 51
Countries citing papers authored by Michael D. Latham
This map shows the geographic impact of Michael D. Latham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Latham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Latham more than expected).
Fields of papers citing papers by Michael D. Latham
This network shows the impact of papers produced by Michael D. Latham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Latham. The network helps show where Michael D. Latham may publish in the future.
Co-authorship network of co-authors of Michael D. Latham
This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Latham. A scholar is included among the top collaborators of Michael D. Latham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Latham. Michael D. Latham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 17 | |
| 3 | 21 | |
| 4 | Elevated topoisomerase ii top ii levels in alkylating agent aa resistant breast cancer | 2 |
| 5 | Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. | 72 |
| 6 | 26 | |
| 7 | 81 | |
| 8 | Mechanisms of resistance to topoisomerase ii active drugs | 1 |
| 9 | Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. | 131 |
| 10 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.